Amy Silar
Family · Groesbeck, TXNPI 1407424781
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 100 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 11.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $819 and has fallen 89.0% since, to $90 in 2025.
Across 100 payments — averaging $16.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$188
- Novo Nordisk$179
- AstraZeneca$161
- AbbVie$136
- Lilly USA, LLC$134
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$133
- plus $671 from 16 others
What the payments were for
- Food & beverage$1,602100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 12 | $188 |
| Novo Nordisk | 9 | $179 |
| AstraZeneca | 10 | $161 |
| AbbVie | 7 | $136 |
| Lilly USA, LLC | 9 | $134 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $133 |
| GSK | 7 | $111 |
| Sanofi-aventis U.S. LLC | 6 | $89 |
| Dexcom, Inc. | 5 | $80 |
| Novartis | 5 | $69 |
| Merck | 4 | $67 |
| Mylan Specialty L.p. | 4 | $56 |
| Corcept Therapeutics | 2 | $33 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $31 |
| Boehringer Ingelheim | 2 | $24 |
| Bayer | 1 | $18 |
| Halozyme Inc | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $17 |
| Vivus LLC | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Antares Pharma, Inc. | 1 | $13 |
How this compares
$1,602 in reported general payments places this provider in the 75th percentile of 15,456 family providers in Texas.
Other family in Groesbeck
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.